LNTHLantheus Holdings, Inc.

$5B

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$89M+3.6% YoY

Gross Profit

$45M49.9% margin

Operating Income

$12M13.9% margin

Net Income

$10M11.7% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

+4.2%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$406M

Total Liabilities

$291M

Stockholders' Equity

$115M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$86M	+3.6%
Gross Profit	$45M	$44M	+1.6%
Operating Income	$12M	$17M	-26.6%
Net Income	$10M	$13M	-21.4%

Revenue Segments

US Segment

$79M88%

International Segment

$11M12%

LNTH Q4 2019 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena